Simon's practice is focused on technology, M&A and capital markets and he heads the firm’s technology practice.
Simon regularly advises Israeli and foreign clients on their local and international transactions, as well as London Stock Exchange and AIM-listed companies in relation to various securities and company law issues.
Prior to joining Epstein Rosenblum Maoz (ERM), Simon worked in the international corporate team of Gross, Kleinhendler, Hodak, Halevy Greenberg & Co (GKH), where he founded and headed the firms UK Practice Group. Prior to moving to Israel Simon worked at the London offices of Halliwells LLP and Dechert LLP.
Simon has acted on some of the most high profile mergers and acquisitions and capital markets transactions in Israel in recent years, including, the sale of medical device start-up Ventor Technologies to Medtronic for approximately $330 million, the acquisition of Qumranet by Red Hat for approximately US$115 million and AFI Development plc’s $1.4 billion IPO on the London Stock Exchange.
Simon has acted for clients such as Vodafone, the European Investment Bank, ECI Telecom, Netafim, Tate & Lyle and Medtronic as well as for start-ups and investors in the technology, life sciences and renewable energy fields.
Simon is recommended by the Legal 500 for hi-tech, start-ups and venture capital work.
Simon has a bachelor degree in law (LLB) from the University of Manchester and completed the legal practice course in London, receiving a distinction in his law society final exam.
Simon is a member of the Israel Bar and is also a practicing solicitor in England and Wales. Simon speaks Hebrew and English.